Although the methods for detecting ESR1 or HER2 in breast cancer biopsies by immunohistochemistry are well established [29], AR immunohistochemistry performed on tumor biopsies is not routine or standardized leading to a wide variation in the reported number of AR-positive breast cancer cases [27, 28]. The gene discussed is AR; the disease is neoplasm.